Imaging alpha7-nAChRs in Traumatic Brain Injury
创伤性脑损伤中 α7-nAChR 的成像
基本信息
- 批准号:8761997
- 负责人:
- 金额:$ 20.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcetylcholineAcetylcholinesteraseAcuteAgreementAlzheimer&aposs DiseaseAnimal ModelAnimalsAnxietyAstrocytesAutonomic ganglionAutoradiographyAwarenessBilateralBindingBiochemicalBiologicalBiological MarkersBrain regionCerebrumCholineComplexControl AnimalDataDiagnosticDiffuseDiseaseDrug AddictionEventExhibitsFutureGoalsHippocampus (Brain)HumanImageImmunofluorescence ImmunologicIn VitroIndustryInflammationLabelLaboratoriesLinkMeasuresMediator of activation proteinMental DepressionMicrogliaModelingMultiple SclerosisMusNeuraxisNeurogliaNeuronsNicotinic ReceptorsPapioPhysiologyPositron-Emission TomographyPrimatesPropertyProteinsPublic HealthRattusReportingRodentSchizophreniaSensory GangliaSeveritiesSideSimulateSiteSpecificityStaining methodStainsTBI PatientsTraumatic Brain Injuryalpha-bungarotoxin receptorbasebrain tissuecontrolled cortical impactdensityin vivoinnovationmacrophagemolecular imagingnonhuman primatenovelprognosticpublic health relevanceradioligandradiotracerreceptortool
项目摘要
DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a major public health problem that raises the need to accurately measure its effects non-invasively. A biological target mechanistically linked to TBI and suitable for molecular imaging with diagnostic and prognostic implications could provide a quantitative non-invasive biomarker for TBI. Presently, such a biomarker does not exist. Multiple lines of evidence have demonstrated that TBI triggers a biochemical cascade that reduces the density of cerebral alpha7-nAChRs, one of the major subtypes of nicotinic acetylcholine receptors. Preliminary data from our laboratory has demonstrated that our novel positron-emission tomography (PET) radiotracer [18F]ASEM can accurately report the distribution of alpha7-nAChRs in control animals and that it exhibits strikin bilateral reduction of binding (32-73%) in rats with controlled cortical impact (CCI) TBI model. Currently, [18F]ASEM is the only alpha7-nAChR radioligand that has demonstrated excellent imaging properties with high specific binding in rodent and non-human primate PET studies. The main objective of this proposal is to validate the PET imaging properties of [18F]ASEM in two models of TBI in rats, focal - CCI and diffuse - impact acceleration (IA). 1) Cerebral alpha7-nAChR binding and distribution will be measured with [18F]ASEM - PET in CCI and IA models of TBI in rats. In agreement with previous in vitro alpha7-nAChR autoradiography data in animals with TBI reported by others and our preliminary PET results, our hypothesis is that the cerebral specific binding of [18F]ASEM in TBI will be significantly reduced. The reduction of the [18F]ASEM specific binding will correlate with the TBI severity and progression. 2) The PET results will be confirmed by immunofluorescent staining that will demonstrate significant alteration of the alpha7-nAChR protein in TBI rat brain tissue (in neurons and glia). The experimental focus of this proposal is to carry out proof-of-concept studies and obtain evidence of the suitability of [18F]ASEM for quantification of alpha7-nAChRs by PET in TBI models in rats. Our future goal is to evaluate alpha7-nAChRs as a potential biomarker of TBI in humans by studying the course of receptor changes in TBI and their sensitivity to the effects of various treatments.
描述(由申请人提供):创伤性脑损伤(TBI)是一个主要的公共卫生问题,它提出了准确地衡量其效果的必要性。与TBI相关的生物学靶标,适用于具有诊断和预后意义的分子成像,可以为TBI提供定量的非侵入性生物标志物。目前,这种生物标志物不存在。多种证据表明,TBI触发了生化级联反应,该级联体降低了大脑α7-NACHR的密度,这是烟碱乙酰胆碱受体的主要亚型之一。 我们实验室的初步数据表明,我们的新型正电子发射层造影术(PET)radiotracer [18F] ASEM可以准确地报告对照动物中α7-NACHRS的分布,并且它在具有控制性皮质影响(CCI)模型的大鼠中表现出双边脱水的降低(32-73%)。目前,[18F] ASEM是唯一一种在啮齿动物和非人类灵长类动物宠物研究中表现出具有高特异性结合的出色成像特性的α7-NACHR放射线。该提案的主要目的是验证在大鼠,焦点-CCI和弥漫性撞击加速度(IA)的两个TBI模型中[18F] ASEM的PET成像特性。 1)将用[18F] ASEM -PET在CCI和TBI的IA模型中测量脑α7 -NACHR结合和分布。与其他人报道的动物和我们的初步宠物结果的动物中先前的体外α7-NACHR放射自显影数据一致,我们的假设是[18F] ASEM在TBI中的大脑特异性结合将大大降低。 [18F] ASEM特异性结合的降低将与TBI的严重程度和进展相关。 2)PET结果将通过免疫荧光染色来证实,该染色将表明TBI大鼠脑组织(在神经元和神经胶质素中)中α7-NACHR蛋白的显着改变。 该提案的实验重点是进行概念证明研究,并获得[18F] ASEM对大鼠TBI模型中PET定量α7-NACHR的适用性的证据。我们的未来目标是通过研究TBI的受体变化及其对各种治疗作用的敏感性来评估人类中TBI的潜在生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew G Horti其他文献
Andrew G Horti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew G Horti', 18)}}的其他基金
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
9912886 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
10260389 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
PET Imaging of alpha 7 and alpha4beta2-nAChR in Schizophrenia: Cognitive Relationships
精神分裂症中 α7 和 α4β2-nAChR 的 PET 成像:认知关系
- 批准号:
10165041 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
10390394 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
PET imaging of soluble epoxide hydrolase (sEH) in human subjects
人体可溶性环氧化物水解酶 (sEH) 的 PET 成像
- 批准号:
9916950 - 财政年份:2017
- 资助金额:
$ 20.25万 - 项目类别:
PET imaging of alpha 7 and alpha4beta2-nAChR in schizophrenia: Cognitive Relationships
精神分裂症中 α7 和 α4β2-nAChR 的 PET 成像:认知关系
- 批准号:
9762230 - 财政年份:2015
- 资助金额:
$ 20.25万 - 项目类别:
Extrathalamic nAChR-PET for Imaging Neurodegeneration
丘脑外 nAChR-PET 用于神经退行性疾病成像
- 批准号:
8449414 - 财政年份:2011
- 资助金额:
$ 20.25万 - 项目类别:
Extrathalamic nAChR-PET for Imaging Neurodegeneration
丘脑外 nAChR-PET 用于神经退行性疾病成像
- 批准号:
8713891 - 财政年份:2011
- 资助金额:
$ 20.25万 - 项目类别:
Extrathalamic nAChR-PET for Imaging Neurodegeneration
丘脑外 nAChR-PET 用于神经退行性疾病成像
- 批准号:
8540332 - 财政年份:2011
- 资助金额:
$ 20.25万 - 项目类别:
Extrathalamic nAChR-PET for Imaging Neurodegeneration
丘脑外 nAChR-PET 用于神经退行性疾病成像
- 批准号:
8047647 - 财政年份:2011
- 资助金额:
$ 20.25万 - 项目类别:
相似国自然基金
伪旋毛虫乙酰胆碱酯酶破坏肠道ILC2s的ChAT-ACh通路实现免疫逃逸的机制研究
- 批准号:32302960
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
元宝枫种子中抑制乙酰胆碱酯酶活性成分的高效发现及其作用机理研究
- 批准号:32100323
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
元宝枫种子中抑制乙酰胆碱酯酶活性成分的高效发现及其作用机理研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠神经元芳香烃受体/乙酰胆碱酯酶信号通路介导的青黛肠道不良反应研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
具有乙酰胆碱酯酶抑制活性间苯三酚衍生物的发现及其作用机制研究
- 批准号:
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
A Vitamin K analog countermeasure for organophosphate poisoning
维生素 K 类似物治疗有机磷中毒的对策
- 批准号:
10602913 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Targeting Cholinergic Deficits with Retinoic Acid after TBI
使用视黄酸治疗 TBI 后的胆碱能缺陷
- 批准号:
10741924 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Uncharted Territory: Mapping and Manipulating Cholinergic Basal Forebrain Activity in a Mouse Model of Alzheimer's Disease
未知领域:绘制和操纵阿尔茨海默病小鼠模型中的胆碱能基础前脑活动
- 批准号:
10537906 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Novel oxime antidotes for an organophosphate insecticide requiring bioactivation
用于需要生物活化的有机磷杀虫剂的新型肟解毒剂
- 批准号:
10629574 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Impact of chronic alcohol on neuronal cholinergic signaling
慢性酒精对神经元胆碱能信号的影响
- 批准号:
10667844 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别: